Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:01840343n
Noun Concept
Categories: Chemicals that do not have a ChemSpider ID assigned, Drugboxes which contain changes to verified fields, Antibody-drug conjugate, All articles with vague or ambiguous time, Breakthrough therapy
EN
brentuximab vedotin  Adcetris  ATC code L01XC12  ATCvet code QL01XC12  brentuximab
EN
Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma, a type of T cell non-Hodgkin lymphoma. Wikipedia
Definitions
Relations
Sources
EN
Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma, a type of T cell non-Hodgkin lymphoma. Wikipedia
Pharmaceutical drug Wikidata
IS A
compound
medicine
antibody-drug conjugate
biopharmaceutical
immunoconjugate
HAS PART
monomethyl auristatin E
MEDICAL CONDITION TREATED
lymphoma
anaplastic large-cell lymphoma
mycosis fungoides
T-cell lymphoma
diffuse large B-cell lymphoma
+1 relations
Wikipedia
EN
brentuximab vedotin
Wikidata
EN
brentuximab vedotin
Wikipedia Redirections
EN
ADCETRIS, ATC code L01XC12, ATCvet code QL01XC12, brentuximab, Brentuximab Vedotin, ECHELON-1, SGN-35, Sgn35
Wikidata Alias
EN
Adcetris, brentuximab, cAC10-vcMMAE, SGN-35

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License